259 related articles for article (PubMed ID: 2056279)
41. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor.
Balduini CL; Frassoni F; Noris P; Klersy C; Iannone AM; Bacigalupo A; Giorgiani G; Di Pumpo M; Locatelli F
Br J Haematol; 2001 Sep; 114(4):951-3. PubMed ID: 11564091
[TBL] [Abstract][Full Text] [Related]
42. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.
Falkenburg JH; Wafelman AR; Joosten P; Smit WM; van Bergen CA; Bongaerts R; Lurvink E; van der Hoorn M; Kluck P; Landegent JE; Kluin-Nelemans HC; Fibbe WE; Willemze R
Blood; 1999 Aug; 94(4):1201-8. PubMed ID: 10438707
[TBL] [Abstract][Full Text] [Related]
43. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
[TBL] [Abstract][Full Text] [Related]
44. Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells.
Hoffmann T; Theobald M; Bunjes D; Weiss M; Heimpel H; Heit W
Bone Marrow Transplant; 1993 Jul; 12(1):1-8. PubMed ID: 8374531
[TBL] [Abstract][Full Text] [Related]
45. Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay.
Smit WM; Rijnbeek M; van Bergen CA; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1998 Mar; 21(6):553-60. PubMed ID: 9543058
[TBL] [Abstract][Full Text] [Related]
46. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.
de Rijke B; van Horssen-Zoetbrood A; Beekman JM; Otterud B; Maas F; Woestenenk R; Kester M; Leppert M; Schattenberg AV; de Witte T; van de Wiel-van Kemenade E; Dolstra H
J Clin Invest; 2005 Dec; 115(12):3506-16. PubMed ID: 16322791
[TBL] [Abstract][Full Text] [Related]
47. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.
Vogt MH; Goulmy E; Kloosterboer FM; Blokland E; de Paus RA; Willemze R; Falkenburg JH
Blood; 2000 Nov; 96(9):3126-32. PubMed ID: 11049993
[TBL] [Abstract][Full Text] [Related]
48. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.
Dolstra H; Fredrix H; Maas F; Coulie PG; Brasseur F; Mensink E; Adema GJ; de Witte TM; Figdor CG; van de Wiel-van Kemenade E
J Exp Med; 1999 Jan; 189(2):301-8. PubMed ID: 9892612
[TBL] [Abstract][Full Text] [Related]
49. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex.
Vinci G; Masset M; Semana G; Vernant JP
Transplantation; 1994 Aug; 58(3):361-7. PubMed ID: 8053061
[TBL] [Abstract][Full Text] [Related]
50. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
[TBL] [Abstract][Full Text] [Related]
51. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
[TBL] [Abstract][Full Text] [Related]
52. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
[TBL] [Abstract][Full Text] [Related]
53. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
54. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection.
Vogt MH; de Paus RA; Voogt PJ; Willemze R; Falkenburg JH
Blood; 2000 Feb; 95(3):1100-5. PubMed ID: 10648428
[TBL] [Abstract][Full Text] [Related]
55. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
[TBL] [Abstract][Full Text] [Related]
56. Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation.
Falkenburg JH; Faber LM; van den Elshout M; van Luxemburg-Heijs SA; Hooftman-den Otter A; Smit WM; Voogt PJ; Willemze R
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):305-9. PubMed ID: 8280712
[TBL] [Abstract][Full Text] [Related]
57. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
[TBL] [Abstract][Full Text] [Related]
58. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
[TBL] [Abstract][Full Text] [Related]
59. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of in vitro cytotoxic T lymphocyte assays as a predictive test for the occurrence of graft vs host disease.
Fontaine P; Langlais J; Perreault C
Immunogenetics; 1991; 34(4):222-6. PubMed ID: 1916950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]